Glucose degradation products and peritoneal membrane function

被引:0
|
作者
Witowski, J
Bender, TO
Gahl, GM
Frei, U
Jörres, A
机构
[1] Humboldt Univ, Fak Med, Univ Klinikum Charite, Dept Nephrol & Med Intens Care, D-13353 Berlin, Germany
[2] Univ Poznan, Sch Med, Dept Pathophysiol, Poznan, Poland
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2001年 / 21卷 / 02期
关键词
glucose degradation products; bioincompatibility; peritoneal dialysis fluids; peritoneal mesothelium;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background:The bioincompatibility of peritoneal dialysis fluids (PDF) in current use has been partially attributed to the presence of glucose degradation products (GDPs), which are generated during heat sterilization of PDF. Several of the GDPs have been identified and we have recently demonstrated that these GDPs per se may impair the viability and function of human peritoneal mesothelial cells (HPMC) in vitro. It is also possible that GDP-related toxicity is further exacerbated by the milieu of PDF. We review the current literature on GDP and present the results of experiments comparing the impact of heat- and filter-sterilized PDF on the viability and function of HPMC. Methods: Peritoneal dialysis fluids with low (1.5%) and high (4.25%) glucose concentrations were laboratory prepared according to the standard formula and sterilized either by heat (H-PDF; 121 degreesC, 0.2 MPa, 20 minutes) or filtration (F-PDF; 0.2 mu). The buildup of GDP was confirmed by UV absorbance at 284 nm. Confluent HPMC monolayers were exposed to these solutions mixed 1:1 with standard M199 culture medium. After 24 hours, cell viability was assessed with the MTT assay, and interleukin-1 beta -stimulated monocyte chemotactic protein-1 (MCP-1) release with specific immunoassay. Results: Exposure of HPMC to H-PDF resulted in a significant decrease in cell viability, with solutions containing 4.25% glucose being more toxic than 1.5% glucose-based PDF (27.4% +/- 3.4% and 53.4% +/- 11.0% of control values, respectively). In contrast, viability of HPMC exposed to F-PDF was not different from that of control cells. Moreover, treatment with H-PDF impaired the release of MCP-1 from HPMC to a significantly greater degree compared to F-PDF (17.4% and 24.9% difference for low and high glucose PDF, respectively). Conclusions: Exposure of HPMC to H-PDF significantly impairs cell viability and the capacity for generating MCP-1 compared to F-PDF. This effect is likely to be mediated by GDPs present in H-PDF but not in F-PDF.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [31] Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid
    Ishikawa, N
    Miyata, T
    Ueda, Y
    Inagi, R
    Izuhara, Y
    Yuzawa, H
    Onogi, H
    Nishina, M
    Nangaku, M
    de Strihou, CV
    Kurokawa, K
    KIDNEY INTERNATIONAL, 2003, 63 (01) : 331 - 339
  • [32] Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells
    Alhamdani, Mohamed-Saiel Saeed
    Al-Kassir, Abdul-Hameed A. -M.
    Abbas, Fawzi K. H.
    Jaleel, Nidham A.
    Al-Taee, Maha F.
    NEPHRON CLINICAL PRACTICE, 2007, 107 (01): : C26 - C34
  • [33] A STUDY OF THE CLINICAL AND BIOCHEMICAL PROFILE OF PERITONEAL DIALYSIS FLUID LOW IN GLUCOSE DEGRADATION PRODUCTS
    Lai, Kar Neng
    Lam, Man Fai
    Leung, Joseph C. K.
    Chan, Loretta Y.
    Lam, Christopher W. K.
    Chan, Iris H. S.
    Chan, Hoi Wong
    Li, Chun Sang
    Wong, Sunny S. H.
    Ho, Yiu Wing
    Cheuk, Au
    Tong, Matthew K. L.
    Tang, Sydney C. W.
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (03): : 280 - 291
  • [34] ASSOCIATIONS BETWEEN PERITONEAL GLUCOSE EXPOSURE, GLUCOSE DEGRADATION PRODUCT EXPOSURE, AND PERITONEAL MEMBRANE TRANSPORT CHARACTERISTICS IN PERITONEAL DIALYSIS PATIENTS: SECONDARY ANALYSIS OF THE balANZ TRIAL
    Nataatmadja, Melissa S.
    Johnson, David W.
    Pascoe, Elaine M.
    Darssan, Darsy
    Hawley, Carmel M.
    Cho, Yeoungjee
    PERITONEAL DIALYSIS INTERNATIONAL, 2018, 38 (05): : 349 - 355
  • [35] Inflammation and membrane characteristics are more important in the deterioration of peritoneal membrane function than glucose load
    Van Biesen, W
    Dequidt, C
    Vijt, D
    Lameire, N
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V342 - V343
  • [36] Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids
    Sabrina Gensberger-Reigl
    Ingrid Weigel
    Joachim Stützer
    Andrea Auditore
    Tim Nikolaus
    Monika Pischetsrieder
    Scientific Reports, 12
  • [37] Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids
    Gensberger-Reigl, Sabrina
    Weigel, Ingrid
    Stuetzer, Joachim
    Auditore, Andrea
    Nikolaus, Tim
    Pischetsrieder, Monika
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [38] THE INFLUENCE OF INITIAL PERITONEAL TRANSPORT CHARACTERISTICS, INFLAMMATION, AND HIGH GLUCOSE EXPOSURE ON PROGNOSIS FOR PERITONEAL MEMBRANE FUNCTION
    Jose Fernandez-Reyes, M.
    Auxiliadora Bajo, M.
    Del Peso, Gloria
    Ossorio, Marta
    Diaz, Raquel
    Carretero, Beatriz
    Selgas, Rafael
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (06): : 636 - 644
  • [39] Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells
    Witowski, J
    Korybalska, K
    Ksiazek, K
    Wisniewska-Elnur, J
    Jörres, A
    Lage, C
    Schaub, TP
    Passlick-Deetjen, J
    Breborowicz, A
    Grzegorzewska, A
    Ksiazek, A
    Liberek, T
    Lichodziejewska-Niemierko, M
    Majdan, M
    Rutkowski, B
    Stompór, T
    Sulowicz, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 917 - 924
  • [40] The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients
    Cho, Yeoungjee
    Johnson, David W.
    Badve, Sunil V.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    Wiggins, Kathryn J.
    KIDNEY INTERNATIONAL, 2013, 84 (05) : 969 - 979